Pentoxifylline in Lupus Nephritis

Summary

Pentoxifylline in Lupus Nephritis is a clinical trial^[1].

Key Facts

• Pentoxifylline in Lupus Nephritis's instance of is recorded as clinical trial^[2].
• Pentoxifylline in Lupus Nephritis's start time is recorded as +2019-12-31T00:00:00Z^[3].
• Pentoxifylline in Lupus Nephritis's end time is recorded as +2021-12-31T00:00:00Z^[4].
• Pentoxifylline in Lupus Nephritis's contributor to the creative work or subject is recorded as University of Cincinnati^[5].
• Pentoxifylline in Lupus Nephritis's sponsor is recorded as MetroHealth Medical Center^[6].
• Pentoxifylline in Lupus Nephritis's main subject is recorded as lupus nephritis^[7].
• Pentoxifylline in Lupus Nephritis's main subject is recorded as nephritis^[8].
• Pentoxifylline in Lupus Nephritis's number of participants is recorded as {'unit': '1', 'amount': '+40'}^[9].
• Pentoxifylline in Lupus Nephritis's title is recorded as A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Pentoxifylline or Placebo in Addition to Standard of Care for Treatment of Proteinuria in Patients With Active Lupus Nephritis.^[10].
• Pentoxifylline in Lupus Nephritis's short name is recorded as Pentoxifylline^[11].
• Pentoxifylline in Lupus Nephritis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Pentoxifylline in Lupus Nephritis's ClinicalTrials.gov ID is recorded as NCT03859570^[13].
• Pentoxifylline in Lupus Nephritis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+90'}^[14].
• Pentoxifylline in Lupus Nephritis's clinical trial phase is recorded as phase IV clinical trial^[15].
• Pentoxifylline in Lupus Nephritis's research site is recorded as MetroHealth Medical Center^[16].
• Pentoxifylline in Lupus Nephritis's study type is recorded as interventional study^[17].